StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research report report published on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other research analysts have also weighed in on SRNE. HC Wainwright lowered their price objective on Sorrento Therapeutics from $20.00 to $13.00 in […]
StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research note released on Wednesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also weighed in on SRNE. Dawson James lowered shares of Sorrento Therapeutics from a buy rating to a neutral rating […]
StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a report issued on Tuesday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other equities analysts have also issued reports about the company. Dawson James lowered Sorrento Therapeutics from a buy rating to a neutral rating in a research […]
StockNews.com started coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research note released on Monday. The firm issued a hold rating on the biopharmaceutical company’s stock. A number of other research firms have also weighed in on SRNE. Dawson James lowered shares of Sorrento Therapeutics from a buy rating to a […]
Research analysts at StockNews.com assumed coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Rating) in a research report issued to clients and investors on Monday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Other analysts also recently issued research reports about the company. HC Wainwright dropped their price objective on Sorrento […]